HORMONE RECEPTOR POSITIVE BREAST CARCINOMA

Clinical trials for HORMONE RECEPTOR POSITIVE BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HORMONE RECEPTOR POSITIVE BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 4 Completed 1

New 'Smart Bomb' drug targets Tough-to-Treat breast cancer

Disease control Not yet recruiting

This study is testing a new drug called ARX788 for people with advanced HER2-low breast cancer that has spread or cannot be removed by surgery. ARX788 is an antibody-drug conjugate, which works like a 'smart bomb'—it attaches to cancer cells and delivers a toxin to kill them. The…

Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CARCINOMA

Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

HORMONE RECEPTOR POSITIVE BREAST CARCINOMA

Get alerted when new HORMONE RECEPTOR POSITIVE BREAST CARCINOMA trials appear

New 'Smart Bomb' drug targets Tough-to-Treat breast cancer